Efficacy and Safety of Linagliptin in Asian Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: A 24-Week, Randomized, Phase III Clinical Trial

被引:0
|
作者
Wang, Weiqing
Yang, Jinkui
Yang, Gangyi
Gong, Yan
Woerle, Hans-Juergen
Ning, Guang
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1177-P
引用
收藏
页码:A307 / A307
页数:1
相关论文
共 50 条
  • [1] Efficacy and safety of linagliptin in Asian patients with type 2 diabetes mellitus inadequately controlled by metformin: A multinational 24-week, randomized clinical trial
    Wang, Weiqing
    Yang, Jinkui
    Yang, Gangyi
    Gong, Yan
    Patel, Sanjay
    Zhang, Candice
    Izumoto, Toshiyasu
    Ning, Guang
    [J]. JOURNAL OF DIABETES, 2016, 8 (02) : 229 - 237
  • [2] Efficacy and Safety of Linagliptin Monotherapy in Asian Patients With Inadequately Controlled Type 2 Diabetes Mellitus: A 24-Week, Randomized, Phase III Clinical Trial
    Chen, Yuhong
    Ning, Guang
    Wang, Changjiang
    Gong, Yan
    Woerle, Hans-Juergen
    Wang, Weiqing
    [J]. DIABETES, 2013, 62 : A302 - A302
  • [3] Efficacy and safety of linagliptin monotherapy in Asian patients with inadequately controlled type2 diabetes mellitus: A multinational, 24-week, randomized, clinical trial
    Chen, Yuhong
    Ning, Guang
    Wang, Changjiang
    Gong, Yan
    Patel, Sanjay
    Zhang, Candice
    Izumoto, Toshiyasu
    Woerle, Hans-Juergen
    Wang, Weiqing
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2015, 6 (06): : 692 - 698
  • [4] Efficacy and safety of linagliptin in persons with Type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24-week randomized study
    Owens, D. R.
    Swallow, R.
    Dugi, K. A.
    Woerle, H. J.
    [J]. DIABETIC MEDICINE, 2011, 28 (11) : 1352 - 1361
  • [5] Efficacy and safety of linagliptin in persons with Type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24-week randomized study (vol 28, pg 1352, 2011)
    Owens, D. R.
    Swallow, R.
    Dugi, K. A.
    Woerle, H. J.
    [J]. DIABETIC MEDICINE, 2012, 29 (01) : 158 - 158
  • [6] Efficacy and Safety of Linagliptin in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy
    Taskinen, Marja-Riitta
    Rosenstock, Julio
    Tamminen, Ilkka
    Kubiak, Rene
    Patel, Sanjay
    Dugi, Klaus A.
    Woerle, Hans-Juergen
    [J]. DIABETES, 2010, 59 : A158 - A158
  • [7] Empagliflozin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Linagliptin and Metformin: A 24-Week Randomized, Double-Blind, Parallel-Group Trial
    Softeland, Eirik
    Meier, Juris J.
    Vangen, Bente
    Toorawa, Robert
    Maldonado-Lutomirsky, Mario
    Broedl, Uli C.
    [J]. DIABETES CARE, 2017, 40 (02) : 201 - 209
  • [8] Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial
    Mathieu, Chantal
    Dandona, Paresh
    Gillard, Pieter
    Senior, Peter
    Hasslacher, Christoph
    Araki, Eiichi
    Lind, Marcus
    Bain, Stephen C.
    Jabbour, Serge
    Arya, Niki
    Hansen, Lars
    Thoren, Fredrik
    Langkilde, Anna Maria
    [J]. DIABETES CARE, 2018, 41 (09) : 1938 - 1946
  • [9] Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial
    Wilding, J. P. H.
    Charpentier, G.
    Hollander, P.
    Gonzalez-Galvez, G.
    Mathieu, C.
    Vercruysse, F.
    Usiskin, K.
    Law, G.
    Black, S.
    Canovatchel, W.
    Meininger, G.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (12) : 1267 - 1282
  • [10] A randomized clinical trial of the safety and efficacy of sitagliptin in patients with type 2 diabetes mellitus inadequately controlled by acarbose alone
    Wang, Weiqing
    Ning, Guang
    Ma, Jianhua
    Liu, Xiaomin
    Zheng, Shaoxiong
    Wu, Fan
    Xu, Lei
    O'Neill, Edward A.
    Fujita, Kenji P.
    Engel, Samuel S.
    Kaufman, Keith D.
    Shankar, R. Ravi
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (04) : 693 - 699